Covaxin gets Brazilian regulator's conditional nod, Bharat Biotech to export four million doses

Anvisa, also known as the The National Health Surveillance Agency of Brazil, has approved the import of Bharat Biotech's Covaxin and Russia's Sputnik V vaccine into that country.

Brazil has given clearance to the proposal to import Bharat Biotech's Covid-19 vaccine Covaxin into the South American country with some conditions. The National Health Surveillance Agency of Brazil- Anvisa - had earlier denied permission to import Covaxin after authorities found that the Indian plant in which the jab was being made did not meet the good manufacturing practice (GMP) requirements. The Brazilian health regulator also approved another proposal to import Russia's Sputnik V vaccine into that country.